fda zepbound news - Search News

FDA, obstructive sleep apnea

People on MSN · 2d

Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.

CNN on MSN · 6d

FDA approves weight-loss drug Zepbound for obstructive sleep apnea

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

McKnight's Long-Term Care News · 1d

FDA approves Zepbound for sleep apnea in patients with obesity

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

2don MSN

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

7d

FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage

Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for ...

Everyday Health3d

FDA Says Shortages of GLP-1 Drugs Mounjaro and Zepbound Are Over

Tirzepatide, the main ingredient in Mounjaro and Zepbound, is no longer in shortage, according to the U.S. Food and Drug ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results